Signals and receptors

Cold Spring Harbor Perspectives in Biology

Volumn 8, Issue 4, 2016, Pages

  Heldin, Carl Henrik ^a   Lu, Benson ^b   Evans, Ron ^b   Gutkind, J Silvio ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; LIGAND; TUMOR NECROSIS FACTOR RECEPTOR;

BINDING SITE; BIOLOGICAL MODEL; CELL COMMUNICATION; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

BINDING SITES; CELL COMMUNICATION; GENE EXPRESSION REGULATION; LIGANDS; MODELS, BIOLOGICAL; PROTEIN DOMAINS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 84962361088     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a005900     Document Type: Article

References (190)

1. Aggarwal BB. 2003. Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol 3: 745-756.
2. Amit I, Citri A, Shay T, Lu Y, Katz M, Zhang F, Tarcic G, Siwak D, Lahad J, Jacob-Hirsch J, et al. 2007. A module of negative feedback regulators defines growth factor signaling. Nat Genet 39: 503-512.
3. Anastasiadis PZ, Reynolds AB. 2001. Regulation of Rho GTPases by p120-catenin. Curr Opin Cell Biol 13: 604.
4. Ancot F, Foveau B, Lefebvre J, Leroy C, Tulasne D. 2009. Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity. Oncogene 28: 2185-2195.
5. Andl CD, Mizushima T, Nakagawa H, Oyama K, Harada H, Chruma K, Herlyn M, Rustgi AK. 2003. Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esoph-ageal keratinocytes in vitro and in vivo. J Biol Chem 278: 1824-1830.
6. Andreeva AV, Kutuzov MA, Voyno-Yasenetskaya TA. 2007. Scaffolding proteins in G-protein signaling. J Mol Signal 2: 13.
7. Arkhipov A, Shan Y, Das R, Endres NF, Eastwood MP, Wemmer DE, Kuriyan J, Shaw DE. 2013. Architecture and membrane interactions of the EGF receptor. Cell 152: 557-569.
8. Ballon DR, Flanary PL, Gladue DP, Konopka JB, Dohlman HG, Thorner J. 2006. DEP-domain-mediated regulation of GPCR signaling responses. Cell 126: 1079-1093.
9. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM. 1999. PPARg is required for placental, cardiac, and adipose tissue development. Mol Cell 4: 585-595.
10. Benovic JL, Pike LJ, Cerione RA, Staniszewski C, Yoshimasa T, Codina J, Caron MG, Lefkowitz RJ. 1985. Phosphorylation of the mammalian ß-adrenergic receptor by cyclic AMP-dependent protein kinase. Regulation of the rate of receptor phosphorylation and dephosphoryla-tion by agonist occupancy and effects on coupling of the receptor to the stimulatory guanine nucleotide regulatory protein. J Biol Chem 260: 7094-7101.
11. Berman DM, Gilman AG. 1998. Mammalian RGS proteins: Barbarians at the gate. JBiol Chem 273: 1269-1272.
12. Blumer JB, Smrcka AV, Lanier SM. 2007. Mechanistic pathways and biological roles for receptor-independent activators of G-protein signaling. Pharmacol Ther 113: 488-506.
13. Bockaert J, Pin JP. 1999. Molecular tinkering of G protein-coupled receptors: An evolutionary success. EMBO J18: 1723-1729.
14. Bodrikov V Sytnyk V, Leshchyns'ka I, den Hertog J, Schachner M. 2008. NCAM induces CaMKIIa-mediated RPTPa phosphorylation to enhance its catalytic activity and neurite outgrowth. J Cell Biol 182: 1185-1200.
15. Bouschet T, Martin S, Henley JM. 2005. Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane. J Cell Sci 118: 4709-4720.
16. Braga VMM, Yap AS. 2005. The challenges of abundance: Epithelial junctions and small GTPase signalling. Curr Opin Cell Biol 17: 466.
17. Brown GC, Cooper CE. 1994. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 356: 295-298.
18. Brzostowski JA, Kimmel AR. 2001. Signaling at zero G: G-protein-inde-pendent functions for 7-TM receptors. Trends Biochem Sci 26: 291297.
19. Burgess AW, Cho HS, Eigenbrot C, Ferguson KM, Garrett TP, Leahy DJ, Lemmon MA, Sliwkowski MX, Ward CW, Yokoyama S. 2003. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol Cell 12: 541-552.
20. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni MR, Hamm HE. 2003. Insights into G protein structure, function, and regulation. Endocr Rev 24: 765-781.
21. Cantrell D. 2014. Signaling in lymphocyte activation. Cold Spring Harb PerspectBiol doi: 10.1101/cshperspect.a018788.
22. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oostuyse B, Dewerchin M, et al. 1999. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98: 147-157.
23. Cavallaro U, Dejana E. 2011. Adhesion molecule signalling: Not always a sticky business. Nat Rev Mol Cell Biol 12: 189-197.
24. Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ. 2000. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288: 2351-2354.
25. Chuang TT, Iacovelli L, Sallese M, De Blasi A. 1996. G protein-coupled receptors: Heterologous regulation of homologous desensitization and its implications. Trends Pharmacol Sci 17: 416-421.
26. Ciraolo E, Iezzi M, Marone R, Marengo S, Curcio C, Costa C, Azzolino O, Gonella C, Rubinetto C, Wu H, et al. 2008. Phosphoinositide 3-kinase p110ß activity: Key role in metabolism and mammary gland cancer but not development. Sci Signal 1: 3.
27. Coso OA, Chiariello M, Yu J-C, Teramoto H, Crespo P, Xu N, Miki T, Gutkind JS. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81: 1137-1146.
28. Costa C, Martin-Conte EL, Hirsch E. 2011. Phosphoinositide 3-kinase p110g in immunity. IUBMB Life 63: 707-713.
29. Croft M. 2009. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 9: 271-285.
30. Daniel JM, Reynolds AB. 1999. The catenin p120ctn interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 19: 3614-3623.
31. Danishpajooh IO, Gudi T, Chen Y, Kharitonov VG, Sharma VS, Boss GR. 2001. Nitric oxide inhibits methionine synthase activity in vivo and disrupts carbon flow through the folate pathway. J Biol Chem 276: 27296-27303.
32. Degnan BM, Vervoort M, Larroux C, Richards GS. 2009. Early evolution of metazoan transcription factors. Curr Opin GenetDev 19: 591-599.
33. De Vos AM, Ultsch M, Kossiakoff AA. 1992. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255: 306-312.
34. Devreotes P, Horwitz AR. 2013. Signaling networks that regulate cell migration. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a005959.
35. Dioum EM, Rutter J, Tuckerman JR, Gonzalez G, Gilles-Gonzalez MA, McKnight SL. 2002. NPAS2: A gas-responsive transcription factor. Science 298: 2385-2387.
36. Dorsam RT, Gutkind JS. 2007. G-Protein-coupled receptors and cancer. Nat Rev Cancer 7: 79-94.
37. Dumstrei K, Wang F, Shy D, Tepass U, Hartenstein V. 2002. Interaction between EGFR signaling and DE-cadherin during nervous system morphogenesis. Development 129: 3983-3994.
38. Endres NF, Das R, Smith AW, Arkhipov A, Kovacs E, Huang Y, Pelton JG, Shan Y, Shaw DE, Wemmer DE, et al. 2013. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 152: 543-556.
39. Evans RM. 2005. The nuclear receptor superfamily: A rosetta stone for physiology. Mol Endocrinol 19: 1429-1438.
40. Faustman D, Davis M. 2010. TNF receptor 2 pathway: Drug target for autoimmune diseases. Nat Rev Drug Discov 9: 482-493.
41. Fedor-Chaiken M, Hein PW, Stewart JC, Brackenbury R, Kinch MS. 2003. E-cadherin binding modulates EGF receptor activation. Cell Commun Adhes 10: 105-118.
42. Feldmann M, Maini RN. 2001. Anti-TNFa therapy of rheumatoid arthritis: What have we learned? Annu Rev Immunol 19: 163-196.
43. Flower DR. 1999. Modelling G-protein-coupled receptors for drug design. Biochim Biophys Acta 1422: 207-234.
44. Forman BM, Chen J, Blumberg B, Kliewer SA, Henshaw R, Ong ES, Evans RM. 1994. Cross-talk among RORa1 and the Rev-erb family of orphan nuclear receptors. Mol Endocrinol 8: 1253-1261.
45. Fox NL, Humphreys R, Luster TA, Klein J, Gallant G. 2010. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy. Expert Opin Biol Ther 10: 1-18.
46. Frisch SM, Screaton RA. 2001. Anoikis mechanisms. Curr Opin Cell Biol 13: 555-562.
47. Fuhrmann G, Chung AC, Jackson KJ, Hummelke G, Baniahmad A, Sutter J, Sylvester I, Scholer HR, Cooney AJ. 2001. Mouse germline restriction of Oct4 expression by germ cell nuclear factor. Dev Cell 1: 377-387.
48. Fukuhara S, Chikumi H, Gutkind JS. 2001. RGS-containing RhoGEFs: The missing link between transforming G proteins and Rho? Oncogene 20: 1661-1668.
49. Geiger B, Yamada KM. 2011. Molecular architecture and function of matrix adhesions. Cold SpringHarb Perspect Biol 3: a005033.
50. Geiger B, Bershadsky A, Pankov R, Yamada KM. 2001. Transmembrane crosstalk between the extracellular matrix and the cytoskeleton. Nat Rev Mol Cell Biol 2: 793-805.
51. Green DR, Llambi F. 2014. Cell death signaling. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a006080.
52. Grosheva I, Shtutman M, Elbaum M, Bershadsky AD. 2001. p120 catenin affects cell motility via modulation of activity of Rho-family GTPases: A link between cell-cell contact formation and regulation of cell locomotion. J Cell Sci 114: 695-707.
53. Gumbiner BM. 2005. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 6: 622-634.
54. Gutkind JS. 1998. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 273: 1839-1842.
55. Gutkind JS. 2000. Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci STKE 2000: re1.
56. Hanyaloglu AC, von Zastrow M. 2008. Regulation of GPCRsbyendocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 48: 537-568.
57. Hardie DG. 2012. Organismal carbohydrate and lipid homeostasis. Cold Spring Harb Perspect Biol 4: a006031.
58. Harrison DA. 2012. The JAK/STAT pathway. Cold Spring Harb Perspect Biol 4: a011205.
59. Hart MJ, Jiang X, Kozasa T, Roscoe W, Singer WD, Gilman AG, Sternweis PC, Bollag G. 1998. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Ga13. Science 280: 2112-2114.
60. Heldin C-H. 1995. Dimerization of cell surface receptors in signal trans-duction. Cell 80: 213-223.
61. Hemmings BA, Restuccia DF. 2012. PI3K-PKB/Akt pathway. Cold Spring Harb Perspect Biol 4: a011189.
62. Hsu SY, Kudo M, Chen T, Nakabayashi K, Bhalla A, van der Spek PJ, van Duin M, Hsueh AJ. 2000. The three subfamilies ofleucine-rich repeat-containing G protein-coupled receptors (LGR): Identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol Endo-crinol 14: 1257-1271.
63. Hu X, Lazar MA. 1999. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402: 93-96.
64. Hubbard KB, Hepler JR. 2006. Cell signalling diversity ofthe Gqa family of heterotrimeric G proteins. Cell Signal 18: 135-150.
65. Huttenlocher A, Horwitz AR. 2011. Integrins in cell migration. Cold Spring Harb Perspect Biol 3: a005074.
66. Hynes RO. 2002. Integrins: Bidirectional, allosteric signaling machines. Cell 110: 673-687.
67. Ingham PW. 2012. Hedgehog signaling. Cold SpringHarb Perspect Biol 4: a011221.
68. Issemann I, Green S. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645-650.
69. Jiang G, Hunter T. 1999. Receptor signaling: When dimerization is not enough. Curr Biol 9: R568-R571.
70. Julius D, Nathans J. 2012. Signaling by sensory receptors. Cold Spring Harb Perspect Biol 4: a005991.
71. Jura N, Endres NF, Engel K, Deindl S, Das R, Lamers MH, Wemmer DE, Zhang X, Kuriyan J. 2009. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 137: 1293-1307.
72. Kallen JA, Schlaeppi JM, Bitsch F, Geisse S, Geiser M, Delhon I, Fournier B. 2002. X-ray structure of the hRORa LBD at 1.63 A: Structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORa. Structure 10: 1697-1707.
73. Kang JS, Liu C, Derynck R. 2009. New regulatory mechanisms of TGFß receptor function. Trends Cell Biol 19: 385-394.
74. Kim N, Stiegler AL, Cameron TO, Hallock PT, Gomez AM, Huang JH, Hubbard SR, Dustin ML, Burden SJ. 2008. Lrp4 is a receptor for Agrin and forms a complex with MuSK. Cell 135: 334-342.
75. Kim NG, Koh E, Chen X, Gumbiner BM. 2011. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci 108: 11930-11935.
76. King-Jones K, Charles JP, Lam G, Thummel CS. 2005. The ecdysone-induced DHR4 orphan nuclear receptor coordinates growth and maturation in Drosophila. Cell 121: 773-784.
77. Kniazeff J, Prezeau L, Rondard P, Pin JP, Goudet C. 2011. Dimers and beyond: The functional puzzles ofclass C GPCRs. Pharmacol Ther 130: 9-25.
78. Kobielak A, Fuchs E. 2004. a-Catenin: At the junction of intercellular adhesion and actin dynamics. Nat Rev Mol Cell Biol 5: 614-625.
79. Kobilka BK. 2011. Structural insights into adrenergic receptor function and pharmacology. Trends Pharmacol Sci 32: 213-218.
80. Kopan R. 2012. Notch signaling. Cold Spring Harb Perspect Biol 4: a011213.
81. Kopan R, Ilagan MXG. 2009. The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell 137: 216-233.
82. Kornbluth S, Fissore R. 2014. Vertebrate reproduction. Cold SpringHarb Perspect Biol doi: 10.1101/cshperspect.a006064.
83. Korshunova I, Mosevitsky M. 2010. Role of the growth-associated protein GAP-43 in NCAM-mediated neurite outgrowth. Adv Exp Med Biol 663: 169-182.
84. Krylova IN, Sablin EP, Moore J, Xu RX, Waitt GM, MacKay JA, Juzumiene D, Bynum JM, Madauss K, Montana V, et al. 2005. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120: 343-355.
85. Laplante M, Sabatini DM. 2012. mTOR signaling. Cold Spring Harb Perspect Biol 4: a011593.
86. Lee MJ, Yaffe MB. 2014. Protein regulation in signal transduction. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a005918.
87. Legate KR, Fassler R. 2009. Mechanisms that regulate adaptor binding to ß-integrin cytoplasmic tails. J Cell Sci 122: 187-198.
88. Legate KR, Wickstrom SA, Fassler R. 2009. Genetic and cell biological analysis of integrin outside-in signaling. Genes Dev 23: 397-418.
89. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. 1998. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102: 1016-1023.
90. Lemmon MA, Schlessinger J. 2010. Cell signaling by receptor tyrosine kinases. Cell 141: 1117-1134.
91. Lengyel E, Sawada K, Salgia R. 2007. Tyrosine kinase mutations in human cancer. Curr Mol Med 7: 77-84.
92. Leushacke M, Barker N. 2011. Lgr5 and Lgr6 as markers to study adult stem cell roles in self-renewal and cancer. Oncogene 31: 3009-3022.
93. Lim X, Nusse R. 2013. Wnt signaling in skin development, homeostasis, and disease. Cold Spring Harb Perspect Biol 5: a008029.
94. Lin S-Y, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung M-C. 2001. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3: 802-808.
95. Liongue C, Ward AC. 2007. Evolution ofClass I cytokine receptors. BMC Evol Biol 7: 120.
96. Locksley RM, Killeen N, Lenardo MJ. 2001. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104: 487-501.
97. Loers G, Schachner M. 2007. Recognition molecules and neural repair. J Neurochem 101: 865-882.
98. Lopez-Ilasaca M, Li W, Uren A, Yu J-C, Kazlauskas A, Gutkind JS, Hei-daran MA. 1997. Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF. Biochem Biophys Res Commun 232: 273-277.
99. Lu TT, Repa JJ, Mangelsdorf DJ. 2001. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J Biol Chem 276: 37735-37738.
100. Luttrell LM, Gesty-Palmer D. 2010. Beyond desensitization: Physiological relevance of arrestin-dependent signaling. Pharmacol Rev 62: 305-330.
101. Lutz S, Shankaranarayanan A, Coco C, Ridilla M, Nance MR, Vettel C, Baltus D, Evelyn CR, Neubig RR, Wieland T, et al. 2007. Structure of Gaq-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoAby GPCRs. Science 318: 1923-1927.
102. Magalhaes AC, Dunn H, Ferguson SS. 2012. Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins. Br J Pharmacol 165: 1717-1736.
103. Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM. 1992. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 6: 329-344.
104. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, et al. 1995. The nuclear receptor superfamily: The second decade. Cell 83: 835-839.
105. May LT, Leach K, Sexton PM, Christopoulos A. 2007. Allosteric modulation of G protein-coupled receptors. Annu Rev Pharmacol Toxicol 47: 1-51.
106. McCaffrey LM, Macara IG. 2012. Signaling pathways in cell polarity. Cold Spring Harb Perspect Biol 4: a009654.
107. Mege RM, Gavard J, Lambert M. 2006. Regulation of cell-cell junctions by the cytoskeleton. Curr Opin Cell Biol 18: 541-548.
108. Miaczynska M, Pelkmans L, Zerial M. 2004. Not just a sink: Endosomes in control of signal transduction. Curr Opin Cell Biol 16: 400-406.
109. Miranti CK, Brugge JS. 2002. Sensing the environment: A historical perspective on integrin signal transduction. Nat Cell Biol 4: E83-E90.
110. Miyamoto S, Teramoto H, Coso OA, Gutkind JS, Burbelo PD, Akiyama SK, Yamada KM. 1995. Integrin function: Molecular hierarchies of cytoskeletal and signaling molecules. J Cell Biol 131: 791-805.
111. Miyamoto S, Teramoto H, Gutkind JS, Yamada KM. 1996. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: Roles of integrin aggregation and occupancy of receptors. J Cell Biol 135: 1633-1642.
112. Moncada S, Palmer RM. 1991. Inhibition of the induction of nitric oxide synthase by glucocorticoids: Yet another explanation for their anti-inflammatory effects? Trends Pharmacol Sci 12: 130-131.
113. Moncada S, Palmer RM, Higgs EA. 1991. Nitric oxide: Physiology, path-ophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
114. Moquin D, Chan FK-M. 2010. The molecular regulation of programmed necrotic cell injury. Trends Biochem Sci 35: 434-441.
115. Morrison DK. 2012. MAP kinase pathways. Cold Spring Harb Perspect Biol 4: a011254.
116. Moser M, Legate KR, Zent R, Fassler R. 2009. The tail ofintegrins, talin, and kindlins. Science 324: 895-899.
117. Moustakas A, Heldin C-H. 2009. The regulation of TGFß signal transduction. Development 136: 3699-3714.
118. Mu Y, Sundar R, Thakur N, Ekman M, Gudey SK, Yakymovych M, Hermansson A, Dimitriou H, Bengoechea-Alonso MT, Ericsson J, et al. 2011. TRAF6 ubiquitinates TGFß type I receptor to promote its cleavage and nuclear translocation in cancer. Nat Commun 2: 330.
119. Nabhan JF, Pan H, Lu Q. 2010. Arrestin domain-containing protein 3 recruits the NEDD4 E3 ligase to mediate ubiquitination of the ß2-adrenergic receptor. EMBO Rep 11: 605-611.
120. Nelson WJ, Nusse R. 2004. Convergence ofWnt, ß-catenin, and cadherin pathways. Science 303: 1483-1487.
121. Newton K, Dixit VM. 2012. Signaling in innate immunity and inflam-mation. Cold Spring Harb Perspect Biol 4: a006049.
122. Newton AC, Bootman M, Scott JD. 2014. Second messengers. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a005926.
123. Ni C-Y, Murphy MP, Golde TE, Carpenter G. 2001. g-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294: 2179-2181.
124. Nimmerjahn F, Ravetch JV 2008. Fcg receptors as regulators of immune responses. Nat Rev Immunol 8: 34-47.
125. Nose A, Nagafuchi A, Takeichi M. 1988. Expressed recombinant cadher-ins mediate cell sorting in model systems. Cell 54: 993-1001.
126. O'Hayre M, Vazquez-Prado J, Kufareva I, Stawiski EW, Handel TM, Seshagiri S, Gutkind JS. 2013. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer 13: 412-424.
127. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. 2005. Regulation ofthe polarity protein Par6 by TGFß receptors controls epithelial cell plasticity. Science 307: 1603-1609.
128. Pardee KI, Xu X, Reinking J, Schuetz A, Dong A, Liu S, Zhang R, Tiefenbach J, Lajoie G, Plotnikov AN, et al. 2009. The structural basis of gas-responsive transcription by the human nuclear hormone receptor REV-ERBß. PLoS Biol 7: e43.
129. Pawson T. 2004. Specificity in signal transduction: From phosphotyro-sine-SH2 domain interactions to complex cellular systems. Cell 116: 191-203.
130. Pece S, Gutkind JS. 2000. Signaling from E-cadherins to the MAPK pathway by the recruitment and activation ofepidermal growth factor receptors upon cell-cell contact formation. JBiol Chem 275: 41227-41233.
131. Pece S, Chiariello M, Murga C, Gutkind JS. 1999. Activation of the protein kinase Akt/PKB by the formation of E-cadherin-mediated cell-cell junctions. Evidence for the association of phosphatidylino-sitol 3-kinase with the E-cadherin adhesion complex. J Biol Chem 274: 19347-19351.
132. Perissi V, Jepsen K, Glass CK, Rosenfeld MG. 2010. Deconstructing repression: Evolving models of co-repressor action. Nat Rev Genet 11: 109-123.
133. Pierce KL, Premont RT, Lefkowitz RJ. 2002. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3: 639-650.
134. Qian X, Karpova T, Sheppard AM, McNally J, Lowy DR. 2004. E-cadher-in-mediated adhesion inhibits ligand-dependent activation ofdiverse receptor tyrosine kinases. EMBO J23: 1739-1748.
135. Raiborg C, Stenmark H. 2009. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458: 445-452.
136. Rajagopal S, Rajagopal K, Lefkowitz RJ. 2010. Teaching old receptors new tricks: Biasing seven-transmembrane receptors. Nat Rev Drug Discov 9: 373-386.
137. Red Brewer M, Choi SH, Alvarado D, Moravcevic K, Pozzi A, Lemmon MA, Carpenter G. 2009. The juxtamembrane region of the EGF receptor functions as an activation domain. Mol Cell 34: 641-651.
138. Reinking J, Lam MM, Pardee K, Sampson HM, Liu S, Yang P, Williams S, White W, Lajoie G, Edwards A, et al. 2005. The Drosophila nuclear receptor e75 contains heme and is gas responsive. Cell 122: 195-207.
139. Renauld J-C. 2003. Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators. Nat Rev Immunol 3: 667-676.
140. Rodgers KR. 1999. Heme-based sensors in biological systems. Curr Opin Chem Biol 3: 158-167.
141. Rosenfeld MG, Lunyak VV, Glass CK. 2006. Sensors and signals: A co-activator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20: 1405-1428.
142. Rosenfeldt H, Vazquez-Prado J, Gutkind JS. 2004. P-REX2, a novel PI-3-kinase sensitive Rac exchange factor. FEBS Lett 572: 167-171.
143. Samelson LE. 2011. Immunoreceptor signaling. Cold Spring Harb Per-spect Biol 3: a011510.
144. Sassone-Corsi P. 2012. The cyclic AMP pathway. Cold Spring Harb Per-spect Biol 4: a011148.
145. Schlee S, Carmillo P, Whitty A. 2006. Quantitative analysis ofthe activation mechanism of the multicomponent growth-factor receptor Ret. Nat Chem Biol 2: 636-644.
146. Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N, Tschopp J. 1997. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kB. Immunity 7: 831-836.
147. Sever R, Brugge JS. 2014. Cancer. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a006098.
148. Sever R, Glass CK. 2013. Signaling by nuclear receptors. Cold Spring Harb Perspect Biol 5: a016709.
149. Shattil SJ, Kim C, Ginsberg MH. 2010. The final steps of integrin activation: The end game. Nat Rev Mol Cell Biol 11: 288-300.
150. Shenoy SK, Lefkowitz RJ. 2011. ß-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol Sci 32: 521-533.
151. Sonoda J, Pei L, Evans RM. 2008. Nuclear receptors: Decoding metabolic disease. FEBS Lett 582: 2-9.
152. Stehlin-Gaon C, Willmann D, Zeyer D, Sanglier S, Van Dorsselaer A, Renaud JP, Moras D, Schule R. 2003. All-trans retinoic acid is a ligand for the orphan nuclear receptor RORß. Nat Struct Biol 10: 820-825.
153. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S. 1997. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med 186: 2045-2050.
154. Suenaert P, Bulteel V, Lemmens L, Noman M, Geypens B, Van Assche G, Geboes K, Ceuppens JL, Rutgeerts P. 2002. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am J Gastroen-terol 97: 2000-2004.
155. Sueyoshi T, Kawamoto T, Zelko I, Honkakoski P, Negishi M. 1999. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem 274: 6043-6046.
156. Suyama K, Shapiro I, Guttman M, Hazan RB. 2002. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2: 301-314.
157. Takai Y, Miyoshi J, Ikeda W, Ogita H. 2008. Nectins and nectin-like molecules: Roles in contact inhibition of cell movement and proliferation. Nat Rev Mol Cell Biol 9: 603-615.
158. Taussig R, Gilman AG. 1995. Mammalian membrane-bound adenylyl cyclases. J Biol Chem 270: 1-4.
159. Terrillon S, Bouvier M. 2004. Roles of G-protein-coupled receptor di-merization. EMBO Rep 5: 30-34.
160. Thibeault S, Rautureau Y, Oubaha M, Faubert D, Wilkes BC, Delisle C, Gratton JP. 2010. S-Nitrosylation of ß-catenin by eNOS-derived NO promotes VEGF-induced endothelial cell permeability. Mol Cell 39: 468-476.
161. Thiery JP, Sleeman JP. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131.
162. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. 1998. SARA, a FYVE domain protein that recruits Smad2 to the TGFß receptor. Cell 95: 779-791.
163. Tsukita S, Furuse M, Itoh M. 2001. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2: 285-293.
164. Umesono K, Murakami KK, Thompson CC, Evans RM. 1991. Direct repeats as selective response elements for the thyroid hormone, reti-noic acid, and vitamin D3 receptors. Cell 65: 1255-1266.
165. van Amerongen R, Mikels A, Nusse R. 2008. Alternative wnt signaling is initiated by distinct receptors. Sci Signal 1: re9.
166. Vaque JP, Dorsam RT, Feng X, Iglesias-Bartolome R, Forsthoefel DJ, Chen Q, Debant A, Seeger MA, Ksander BR, Teramoto H, et al. 2013. A genome-wide RNAi screen reveals a Trio-regulated Rho GTPase circuitry transducing mitogenic signals initiated by G protein-coupled receptors. Mol Cell 49: 94-108.
167. Verma A, Hirsch DJ, Glatt CE, Ronnett GV Snyder SH. 1993. Carbon monoxide: A putative neural messenger. Science 259: 381-384.
168. Vleminckx K, Vakaet L, Mareel M, Fiers W, van Roy F. 1991. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-119.
169. Wang GL, Jiang BH, Rue EA, Semenza GL. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci 92: 5510-5514.
170. Wang X, Lupardus P, Laporte SL, Garcia KC. 2009. Structural biology of shared cytokine receptors. Annu Rev Immunol 27: 29-60.
171. Warnmark A, Treuter E, Wright AP, Gustafsson JA. 2003. Activation functions 1 and 2 of nuclear receptors: Molecular strategies for tran-scriptional activation. Mol Endocrinol 17: 1901-1909.
172. Wedel B, Humbert P, Harteneck C, Foerster J, Malkewitz J, Bohme E, Schultz G, Koesling D. 1994. Mutation of His-105 in the ß1 subunit yields a nitric oxide-insensitive form ofsoluble guanylyl cyclase. Proc Natl Acad Sci 91: 2592-2596.
173. Wehling M. 1997. Specific, nongenomic actions of steroid hormones. Annu Rev Physiol 59: 365-393.
174. Wehrle-Haller B. 2012. Assembly and disassembly of cell matrix adhesions. Curr Opin Cell Biol 24: 569-581.
175. Wehrman T, He X, Raab B, Dukipatti A, Blau H, Garcia KC. 2007. Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron 53: 25-38.
176. Welch HC, Coadwell WJ, Ellson CD, Ferguson GJ, Andrews SR, Erdju-ment-Bromage H, Tempst P, Hawkins PT, Stephens LR. 2002. P-Rex1, a PtdIns(3,4,5)P3- and Gßg-regulated guanine-nucleotide exchange factor for Rac. Cell 108: 809-821.
177. Whistler JL, Enquist J, Marley A, Fong J, Gladher F, Tsuruda P, Murray SR, Von Zastrow M. 2002. Modulation of postendocytic sorting of G protein-coupled receptors. Science 297: 615-620.
178. Willard FS, Kimple RJ, Siderovski DP. 2004. Return of the GDI: The GoLoco motif in cell division. Annu Rev Biochem 73: 925-951.
179. Wrana JL. 2013. Signaling by the TGFß superfamily. Cold Spring Harb Perspect Biol 5: a011197.
180. Yamauchi J, Kawano T, Nagao M, Kaziro Y, Itoh H. 2000. Gi-dependent activation of c-Jun N-terminal kinase in human embryonal kidney 293 cells. J Biol Chem 275: 7633-7640.
181. Yanagisawa M, Anastasiadis PZ. 2006. p120 catenin is essential for mesenchymal cadherin-mediated regulation of cell motility and invasiveness. JCell Biol 174: 1087-1096.
182. Yarden Y, Sliwkowski MX. 2001. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137.
183. Yoshimura A, Mori H, Ohishi M, Aki D, Hanada T. 2003. Negative regulation of cytokine signaling influences inflammation. Curr Opin Immunol 15: 704-708.
184. Yu FX, Zhao B, Panupinthu N, Jewell JL, Lian I, Wang LH, Zhao J, Yuan H, Tumaneng K, Li H, et al. 2012. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150: 780-791.
185. Yuzawa S, Opatowsky Y, Zhang Z, Mandiyan V, Lax I, Schlessinger J. 2007. Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor. Cell 130: 323-334.
186. Zhang J, Huang W, Chua SS, Wei P, Moore D.D. 2002. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 298: 422-424.
187. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J. 2006. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125: 1137-1149.
188. Zikherman J, Weiss A. 2009. Antigen receptor signaling in the rheumatic diseases. Arthritis Res Ther 11: 202.
189. Zoncu R, Efeyan A, Sabatini DM. 2011. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35.
190. Zwang Y, Yarden Y. 2009. Systems biology of growth factor-induced receptor endocytosis. Traffic 10: 349-363.